Viewing Study NCT05735366


Ignite Creation Date: 2025-12-24 @ 4:43 PM
Ignite Modification Date: 2025-12-28 @ 7:38 AM
Study NCT ID: NCT05735366
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-24
First Post: 2023-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors
Sponsor: Chugai Pharmaceutical
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module